跳至主要内容
临床试验/NCT04505306
NCT04505306已完成不适用

Comparison of Short-pulse Subthreshold (532 nm) and Infrared Micropulse (810 nm) Macular Laser for Diabetic Macular Edema

Moorfields Eye Hospital Centre Abu Dhabi1 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
113
试验地点
1
主要终点
Best corrected visual acuity

研究概览

简要总结

When applied according to manufacturer recommendations, short-pulse system may yield more temporary reduction in edema while infrared micropulse system may yield slightly better functional outcomes.

详细描述

Purpose: To assess both anatomic and functional outcomes between short-pulse continuous wavelength and infrared micropulse lasers in the treatment of DME.

Materials and Methods

A prospective interventional study from tertiary care eye hospital - King Khaled Eye Specialist Hospital (Riyadh, Saudi Arabia). Patients with center-involving diabetic macular edema were treated with subthreshold laser therapy. Patients in the micropulse group were treated with the 810-nm diode micropulse scanning laser TxCell™ (IRIDEX Corporation, Mountain View, CA, USA). Laser was applied according to manufacturer recommendations for MicroPulseTM in a confluent mode (low intensity/high density) to the entire area of the macular edema. Patients in the short-pulse group were treated with grid pattern laser with 20ms pulse PASCAL laser 532nm (TopCon Medical Laser Systems, Tokyo, Japan) with EndPoint algorithm, which was either 30% or 50% of testing burn. Main outcome measures included best-corrected visual acuity (BCVA) and foveal thickness at baseline and the last follow-up visit.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • center-involving clinically significant macular edema due to diabetic retinopathy (>300 microns)
  • clear ocular media
  • ETDRS visual acuity >29 letters (Snellen equivalent of 20/150) or better
  • treatment naïve eyes or previously treated with antiangiogenic intravitreal agent(s) more than 6 months ago to allow for long wash-out period

排除标准

  • non-center involving diabetic macular edema
  • previous retinal laser or surgery
  • intravitreal steroid use
  • any condition that may be associated with a risk of macular edema such as age-related macular degeneration, retinal vein occlusion, vitreomacular traction, epiretinal membrane and others.

结局指标

主要结局

Best corrected visual acuity

时间窗: 6 months

ETDRS visual acuity charts

Central foveal thickness

时间窗: 6 months

All patients had central retinal thickness measurement using spectral-domain optical coherence tomography (SD-OCT)(Spectralis, Heidelberg Engineering, Heidelberg, Germany). The SD-OCT B-scan was based on the Spectralis macular raster consisting of 19 horizontals 6 millimeter line scans and a real-time eye tracking system.

次要结局

未报告次要终点

研究者

发起方
Moorfields Eye Hospital Centre Abu Dhabi
申办方类型
Other
责任方
Principal Investigator
主要研究者

Igor Kozak

Consultant Vitreoretinal Surgeon/Clinical Lead

Moorfields Eye Hospital Centre Abu Dhabi

研究点 (1)

Loading locations...

相似试验